Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 75

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 75
---
 not be available to the extent such Claim is based on a
failure of the Investor to deliver or to cause to be delivered the prospectus made available by the Company, if such prospectus was timely
made available by the Company pursuant to or ; and (iv) shall not apply to amounts paid in settlement
of any Claim if such settlement is effected without the prior written consent of the Company, which consent shall not be unreasonably
withheld. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Indemnified
Person and shall survive the transfer of the Registrable Securities by the Investor pursuant to .

| 7 |

b. In
connection with the Registration Statement or any New Registration Statement or prospectus, the Investor agrees to indemnify, hold harmless
and defend, to the same extent and in the same manner as is set forth in , the Company, each of its directors, each
of its officers who signs the Registration Statement or any New Registration Statement, each Person, if any, who controls the Company
within the meaning of Section 20 of the Exchange Act (collectively and together with an Indemnified Person, an “”),
against any Claim or Indemnified Damages to which any of them may become subject, under the Securities Act, the Exchange Act or otherwise,
insofar as such Claim or Indemnified Damages arise out of or are based upon any Violation, in each case to the extent, and only to the
extent, that such Violation occurs in reliance upon and in conformity with written information about the Investor set forth on attached hereto or updated from time to time in writing by the Investor and furnished to the Company by the Investor expressly for
use in connection with such Registration Statement or prospectus or any New Registration Statement or from the failure of the Investor
to deliver or cause to be delivered the prospectus made available by the Company, if such prospectus was timely made available by the
Company pursuant to or ; and, subject to , the Investor will reimburse any legal
or other expenses reasonably incurred (and documented) by such Indemnified Party in connection with investigating or defending any such
Claim; provided, however, that the indemnity agreement contained in this and the agreement with respect to contribution
contained in shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior
written consent of the Investor, which consent shall not be unreasonably withheld;